Literature DB >> 3890156

Antinuclear antibody determination: the present state of diagnostic and clinical relevance.

R Smeenk, T Westgeest, T Swaak.   

Abstract

Determination of antinuclear antibodies (ANA) will gain in diagnostic significance if a specific type of ANA can be related to a defined clinical disorder. The past decade has brought us quite a lot of papers dedicated to this subject. Yet, with exception of the DNA/anti-DNA system, observed correlations have remained scarce or contradictory. Also, still little is known about the pathogenic role of ANA. Perhaps more recent approaches using biochemical technologies will provide us with highly purified nuclear antigens necessary to study possible correlations at a more sophisticated level.

Mesh:

Substances:

Year:  1985        PMID: 3890156     DOI: 10.3109/03009748509102067

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  9 in total

1.  IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.

Authors:  S Barakat; O Meyer; F Torterotot; P Youinou; J P Briand; M F Kahn; S Muller
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 2.  A comparison of assays used for the detection of antibodies to DNA.

Authors:  R Smeenk; K Brinkman; H van den Brink; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 3.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera.

Authors:  S Barakat; J P Briand; N Abuaf; M H van Regenmortel; S Muller
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.

Authors:  S Muller; J P Briand; M H Van Regenmortel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 6.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

7.  Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting.

Authors:  A A Westgeest; H G van den Brink; J de Jong; A J Swaak; R J Smeenk
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

8.  T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.

Authors:  A M Draeger; A J Swaak; H G van den Brink; L A Aarden
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

9.  Clinical significance of anti-Ro antibodies in rheumatoid arthritis.

Authors:  Emilce Schneeberger; Gustavo Citera; Monica Heredia; José Maldonado Cocco
Journal:  Clin Rheumatol       Date:  2008-01-08       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.